Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
CancerRespiratory

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223482

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223482

Global Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 410 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 4800
PDF (Enterprise License) - Printable/Downloadable
USD 7000

Add to Cart

Description

Table of Contents

List of Tables

Global throat cancer diagnostics market is projected to register a substantial CAGR of 7.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Global Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe, China, Japan, South Korea, India, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030.

Growing prevalence of throat cancer

Novel technological advancements in throat cancer diagnostics

Market Players:

Some of the key market players in global throat cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

Thermo Fisher Scientific, Inc.

QIAGEN

Abbott

Siemens Healthcare GmbH

Merck KGAA

Hologic, Inc.

Agilent Technologies, Inc.

Illumina, Inc.

BIOMERIEUX

Myriad Genetics, Inc.

Quest Diagnostics Incorporated.

Bio-Rad Laboratories, Inc.

Koninklijke Philips N.V.

BD

Time Medical Holding

PlexBio

MinFound Medical Systems Co., Ltd

Medonica Co. LTD

CANON MEDICAL SYSTEMS CORPORATION

Sysmex Corporation

SternMed GmbH

FUJIFILM Corporation

Show more

TABLE OF CONTENTS

1 INTRODUCTION 47

  • 1.1 OBJECTIVES OF THE STUDY 47
  • 1.2 MARKET DEFINITION 47
  • 1.3 OVERVIEW OF THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET 47
  • 1.4 LIMITATIONS 49
  • 1.5 MARKETS COVERED 49

2 MARKET SEGMENTATION 52

  • 2.1 MARKETS COVERED 52
  • 2.2 GEOGRAPHICAL SCOPE 53
  • 2.3 YEARS CONSIDERED FOR THE STUDY 54
  • 2.4 CURRENCY AND PRICING 54
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 55
  • 2.6 MULTIVARIATE MODELLING 58
  • 2.7 PRODUCT TYPE LIFELINE CURVE 58
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 59
  • 2.9 DBMR MARKET POSITION GRID 60
  • 2.10 MARKET END USER COVERAGE GRID 61
  • 2.11 VENDOR SHARE ANALYSIS 62
  • 2.12 SECONDARY SOURCES 63
  • 2.13 ASSUMPTIONS 63

3 EXECUTIVE SUMMARY 64

4 PREMIUM INSIGHTS 67

  • 4.1 PESTEL ANALYSIS 70
  • 4.2 PORTER'S FIVE FORCES 71

5 INDUSTRY INSIGHTS 72

6 EPIDEMIOLOGY 73

7 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 74

  • 7.1 REGULATORY SCENARIO IN THE U.S 74
  • 7.2 REGULATORY SCENARIO IN AUSTRALIA 75
  • 7.3 REGULATORY SCENARIO IN JAPAN 75
  • 7.4 REGULATORY SCENARIO IN CHINA 75

8 MARKET OVERVIEW 77

  • 8.1 DRIVERS 79
    • 8.1.1 GROWING PREVALENCE OF THROAT CANCER 79
    • 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 79
    • 8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 80
  • 8.2 RESTRAINTS 80
    • 8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 80
    • 8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 80
  • 8.3 OPPORTUNITIES 81
    • 8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 81
    • 8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 82
    • 8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 82
  • 8.4 CHALLENGES 83
    • 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 83
    • 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 83

9 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 84

  • 9.1 OVERVIEW 85
  • 9.2 INSTRUMENTS 88
    • 9.2.1 PATHOLOGY-BASED INSTRUMENTS 89
      • 9.2.1.1 PCR INSTRUMENTS 89
      • 9.2.1.2 SLIDE STAINING SYSTEMS 89
      • 9.2.1.3 TISSUE PROCESSING SYSTEMS 90
      • 9.2.1.4 CELL PROCESSORS 90
      • 9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 90
    • 9.2.2 IMAGING INSTRUMENTS 90
      • 9.2.2.1 ULTRASOUND SYSTEMS 90
      • 9.2.2.2 CT SYSTEMS 90
      • 9.2.2.3 MRI SYSTEMS 90
      • 9.2.2.4 OTHERS 91
    • 9.2.3 BIOPSY INSTRUMENTS 91
    • 9.2.4 OTHERS 91
  • 9.3 CONSUMABLES & ACCESSORIES 91
    • 9.3.1 KITS 92
      • 9.3.1.1 PCR KITS 92
      • 9.3.1.2 DNA POLYMERASE KITS 92
      • 9.3.1.3 NUCLEIC ACID ISOLATION KITS 92
      • 9.3.1.4 OTHERS 93
    • 9.3.2 REAGENTS 93
      • 9.3.2.1 ASSAYS 93
      • 9.3.2.2 BUFFERS 93
      • 9.3.2.3 PRIMERS 93
      • 9.3.2.4 OTHERS 93
    • 9.3.3 PROBES 93
    • 9.3.4 OTHER CONSUMABLES 93

10 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 94

  • 10.1 OVERVIEW 95
  • 10.2 IMAGING TEST 98
    • 10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 99
    • 10.2.2 MRI 99
    • 10.2.3 CHEST X-RAY 99
    • 10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 99
    • 10.2.5 OTHERS 99
  • 10.3 BLOOD TEST 99
    • 10.3.1 BLOOD CHEMISTRY TESTS 101
    • 10.3.2 COMPLETE BLOOD COUNT (CBC) 101
    • 10.3.3 OTHERS 101
  • 10.4 BIOPSY 101
    • 10.4.1 ENDOSCOPIC BIOPSY 102
    • 10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 102
    • 10.4.3 OTHERS 102
  • 10.5 OTHERS 103

11 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 104

  • 11.1 OVERVIEW 105
  • 11.2 PHARYNGEAL CANCER 108
    • 11.2.1 NASOPHARYNGEAL CANCER 109
    • 11.2.2 OROPHARYNGEAL CANCER 109
    • 11.2.3 HYPOPHARYNGEAL CANCER 109
  • 11.3 LARYNGEAL CANCER 110

12 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 111

  • 12.1 OVERVIEW 112
  • 12.2 STAGE III 115
  • 12.3 STAGE II 115
  • 12.4 STAGE IV 116
  • 12.5 STAGE I 117
  • 12.6 STAGE 0 118

13 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY AGE 119

  • 13.1 OVERVIEW 120
  • 13.2 30-65 123
  • 13.3 65 AND ABOVE 124
  • 13.4 21-29 124
  • 13.5 BELOW 21 125

14 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY END USER 126

  • 14.1 OVERVIEW 127
  • 14.2 HOSPITALS 130
  • 14.3 ASSOCIATED LABS 130
  • 14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
  • 14.5 DIAGNOSTIC IMAGING CENTERS 132
  • 14.6 CANCER RESEARCH INSTITUTES 133
  • 14.7 OTHERS 134

15 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135

  • 15.1 OVERVIEW 136
  • 15.2 DIRECT TENDER 139
  • 15.3 RETAIL SALES 140

16 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY REGION 141

  • 16.1 OVERVIEW 142
  • 16.2 NORTH AMERICA 148
    • 16.2.1 U.S. 158
    • 16.2.2 CANADA 163
    • 16.2.3 MEXICO 168
  • 16.3 EUROPE 173
    • 16.3.1 GERMANY 183
    • 16.3.2 FRANCE 188
    • 16.3.3 U.K. 193
    • 16.3.4 ITALY 198
    • 16.3.5 SPAIN 203
    • 16.3.6 RUSSIA 208
    • 16.3.7 TURKEY 213
    • 16.3.8 NETHERLANDS 218
    • 16.3.9 BELGIUM 223
    • 16.3.10 SWITZERLAND 228
    • 16.3.11 REST OF EUROPE 233
  • 16.4 ASIA-PACIFIC 234
    • 16.4.1 CHINA 245
    • 16.4.2 JAPAN 250
    • 16.4.3 SOUTH KOREA 255
    • 16.4.4 INDIA 260
    • 16.4.5 THAILAND 265
    • 16.4.6 SINGAPORE 270
    • 16.4.7 INDONESIA 275
    • 16.4.8 MALAYSIA 280
    • 16.4.9 PHILIPPINES 285
    • 16.4.10 AUSTRALIA 290
    • 16.4.11 VIETNAM 295
    • 16.4.12 REST OF ASIA-PACIFIC 300
  • 16.5 SOUTH AMERICA 301
    • 16.5.1 BRAZIL 310
    • 16.5.2 ARGENTINA 315
    • 16.5.3 REST OF SOUTH AMERICA 320
  • 16.6 MIDDLE EAST AND AFRICA 321
    • 16.6.1 SAUDI ARABIA 332
    • 16.6.2 U.A.E 337
    • 16.6.3 SOUTH AFRICA 342
    • 16.6.4 EGYPT 347
    • 16.6.5 ISRAEL 352
    • 16.6.6 REST OF MIDDLE EAST AND AFRICA 357

17 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 358

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL 358
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 359
  • 17.3 COMPANY SHARE ANALYSIS: EUROPE 360
  • 17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 361

18 SWOT ANALYSIS 362

19 COMPANY PROFILE 363

  • 19.1 F. HOFFMANN- LA ROCHE LTD 363
    • 19.1.1 COMPANY SNAPSHOT 363
    • 19.1.2 REVENUE ANALYSIS 363
    • 19.1.3 COMPANY SHARE ANALYSIS 364
    • 19.1.4 PRODUCT PORTFOLIO 364
    • 19.1.5 RECENT DEVELOPMENT 364
  • 19.2 FUJIFILM CORPORATION 365
    • 19.2.1 COMPANY SNAPSHOT 365
    • 19.2.2 REVENUE ANALYSIS 365
    • 19.2.3 COMPANY SHARE ANALYSIS 366
    • 19.2.4 PRODUCT PORTFOLIO 366
    • 19.2.5 RECENT DEVELOPMENT 366
  • 19.3 THERMO FISHER SCIENTIFIC INC. 367
    • 19.3.1 COMPANY SNAPSHOT 367
    • 19.3.2 REVENUE ANALYSIS 367
    • 19.3.3 COMPANY SHARE ANALYSIS 368
    • 19.3.4 PRODUCT PORTFOLIO 368
    • 19.3.5 RECENT DEVELOPMENTS 368
  • 19.4 CANON MEDICAL SYSTEMS CORPORATION 369
    • 19.4.1 COMPANY SNAPSHOT 369
    • 19.4.2 REVENUE ANALYSIS 369
    • 19.4.3 COMPANY SHARE ANALYSIS 370
    • 19.4.4 PRODUCT PORTFOLIO 370
    • 19.4.5 RECENT DEVELOPMENT 370
  • 19.5 KONINKLIJKE PHILIPS N.V. 371
    • 19.5.1 COMPANY SNAPSHOT 371
    • 19.5.2 REVENUE ANALYSIS 371
    • 19.5.3 COMPANY SHARE ANALYSIS 372
    • 19.5.4 PRODUCT PORTFOLIO 372
    • 19.5.5 RECENT DEVELOPMENT 373
  • 19.6 ABBOTT 374
    • 19.6.1 COMPANY SNAPSHOT 374
    • 19.6.2 REVENUE ANALYSIS 374
    • 19.6.3 PRODUCT PORTFOLIO 375
    • 19.6.4 RECENT DEVELOPMENTS 375
  • 19.7 AGILENT TECHNOLOGIES, INC. 376
    • 19.7.1 COMPANY SNAPSHOT 376
    • 19.7.2 REVENUE ANALYSIS 376
    • 19.7.3 PRODUCT PORTFOLIO 377
    • 19.7.4 RECENT DEVELOPMENT 377
  • 19.8 BD 378
    • 19.8.1 COMPANY SNAPSHOT 378
    • 19.8.2 REVENUE ANALYSIS 378
    • 19.8.3 PRODUCT PORTFOLIO 379
    • 19.8.4 RECENT DEVELOPMENTS 379
  • 19.9 BEIJING O&D BIOTECH CO., LTD. 380
    • 19.9.1 COMPANY SNAPSHOT 380
    • 19.9.2 PRODUCT PORTFOLIO 380
    • 19.9.3 RECENT DEVELOPMENT 380
  • 19.10 BIO-RAD LABORATORIES, INC. 381
    • 19.10.1 COMPANY SNAPSHOT 381
    • 19.10.2 REVENUE ANALYSIS 381
    • 19.10.3 PRODUCT PORTFOLIO 382
    • 19.10.4 RECENT DEVELOPMENT 382
  • 19.11 FONAR CORP. 383
    • 19.11.1 COMPANY SNAPSHOT 383
    • 19.11.2 REVENUE ANALYSIS 383
    • 19.11.3 PRODUCT PORTFOLIO 384
    • 19.11.4 RECENT DEVELOPMENT 384
  • 19.12 GE HEALTHCARE 385
    • 19.12.1 COMPANY SNAPSHOT 385
    • 19.12.2 REVENUE ANALYSIS 385
    • 19.12.3 PRODUCT PORTFOLIO 386
    • 19.12.4 RECENT DEVELOPMENT 386
  • 19.13 HOLOGIC INC. 387
    • 19.13.1 COMPANY SNAPSHOT 387
    • 19.13.2 REVENUE ANALYSIS 387
    • 19.13.3 PRODUCT PORTFOLIO 388
    • 19.13.4 RECENT DEVELOPMENT 388
  • 19.14 ILLUMINA, INC. 389
    • 19.14.1 COMPANY SNAPSHOT 389
    • 19.14.2 REVENUE ANALYSIS 389
    • 19.14.3 PRODUCT PORTFOLIO 390
    • 19.14.4 RECENT DEVELOPMENT 390
  • 19.15 MEDONICA CO. LTD 391
    • 19.15.1 COMPANY SNAPSHOT 391
    • 19.15.2 PRODUCT PORTFOLIO 391
    • 19.15.3 RECENT DEVELOPMENT 391
Show more
  • 19.16 MERCK KGAA 392
    • 19.16.1 COMPANY SNAPSHOT 392
    • 19.16.2 REVENUE ANALYSIS 392
    • 19.16.3 PRODUCT PORTFOLIO 393
    • 19.16.4 RECENT DEVELOPMENT 393
  • 19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 394
    • 19.17.1 COMPANY SNAPSHOT 394
    • 19.17.2 PRODUCT PORTFOLIO 394
    • 19.17.3 RECENT DEVELOPMENT 394
  • 19.18 MYRIAD GENETICS, INC. 395
    • 19.18.1 COMPANY SNAPSHOT 395
    • 19.18.2 REVENUE ANALYSIS 395
    • 19.18.3 PRODUCT PORTFOLIO 396
    • 19.18.4 RECENT DEVELOPMENT 396
  • 19.19 PLEXBIO 397
    • 19.19.1 COMPANY SNAPSHOT 397
    • 19.19.2 PRODUCT PORTFOLIO 397
    • 19.19.3 RECENT DEVELOPMENT 397
  • 19.20 QIAGEN 398
    • 19.20.1 COMPANY SNAPSHOT 398
    • 19.20.2 REVENUE ANALYSIS 398
    • 19.20.3 PRODUCT PORTFOLIO 399
    • 19.20.4 RECENT DEVELOPMENT 399
  • 19.21 QUEST DIAGNOSTICS INCORPORATED 400
    • 19.21.1 COMPANY SNAPSHOT 400
    • 19.21.2 REVENUE ANALYSIS 400
    • 19.21.3 PRODUCT PORTFOLIO 401
    • 19.21.4 RECENT DEVELOPMENT 401
  • 19.22 SIEMENS HEALTHCARE GMBH 402
    • 19.22.1 COMPANY SNAPSHOT 402
    • 19.22.2 REVENUE ANALYSIS 402
    • 19.22.3 PRODUCT PORTFOLIO 403
    • 19.22.4 RECENT DEVELOPMENT 403
  • 19.23 STERNMED GMBH 404
    • 19.23.1 COMPANY SNAPSHOT 404
    • 19.23.2 PRODUCT PORTFOLIO 404
    • 19.23.3 RECENT DEVELOPMENT 404
  • 19.24 TIME MEDICAL HOLDING. 405
    • 19.24.1 COMPANY SNAPSHOT 405
    • 19.24.2 PRODUCT PORTFOLIO 405
    • 19.24.3 RECENT DEVELOPMENT 405

20 QUESTIONNAIRE 406

21 RELATED REPORTS 410

LIST OF TABLES

  • TABLE 1 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
  • TABLE 2 GLOBAL INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 3 GLOBAL INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 89
  • TABLE 4 GLOBAL PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 89
  • TABLE 5 GLOBAL IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 90
  • TABLE 6 GLOBAL CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
  • TABLE 7 GLOBAL CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 92
  • TABLE 8 GLOBAL KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 92
  • TABLE 9 GLOBAL REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 93
  • TABLE 10 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 97
  • TABLE 11 GLOBAL IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 12 GLOBAL IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 99
  • TABLE 13 GLOBAL BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
  • TABLE 14 GLOBAL BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 100
  • TABLE 15 GLOBAL BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 16 GLOBAL BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 102
  • TABLE 17 GLOBAL OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 18 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 107
  • TABLE 19 GLOBAL PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 20 GLOBAL PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 109
  • TABLE 21 GLOBAL LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 22 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 114
  • TABLE 23 GLOBAL STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 24 GLOBAL STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 25 GLOBAL STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 26 GLOBAL STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 27 GLOBAL STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 118
  • TABLE 28 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 122
  • TABLE 29 GLOBAL 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 123
  • TABLE 30 GLOBAL 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 124
  • TABLE 31 GLOBAL 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 32 GLOBAL BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 33 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
  • TABLE 34 GLOBAL HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
  • TABLE 35 GLOBAL ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION) 131
  • TABLE 36 GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
  • TABLE 37 GLOBAL DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 38 GLOBAL CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 133
  • TABLE 39 GLOBAL OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 134
  • TABLE 40 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
  • TABLE 41 GLOBAL DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 139
  • TABLE 42 GLOBAL RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 140
  • TABLE 43 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
  • TABLE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 153
  • TABLE 45 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 46 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 47 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 48 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 49 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 50 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 51 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 52 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 53 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 54 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 55 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 56 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 57 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 58 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 156
  • TABLE 59 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 156
  • TABLE 60 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 157
  • TABLE 61 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 157
  • TABLE 62 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 63 U.S. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 64 U.S. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 65 U.S. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 66 U.S. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 67 U.S. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 68 U.S. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 69 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 70 U.S. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 71 U.S. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 72 U.S. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 73 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 74 U.S. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 75 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 161
  • TABLE 76 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 161
  • TABLE 77 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 162
  • TABLE 78 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 162
  • TABLE 79 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 80 CANADA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 81 CANADA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 82 CANADA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 83 CANADA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 84 CANADA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 85 CANADA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 86 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 87 CANADA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 88 CANADA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 89 CANADA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 90 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 91 CANADA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 92 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 166
  • TABLE 93 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 166
  • TABLE 94 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 167
  • TABLE 95 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 167
  • TABLE 96 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 97 MEXICO INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 98 MEXICO PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 99 MEXICO IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 100 MEXICO CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 101 MEXICO KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 102 MEXICO REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 103 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 104 MEXICO IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 105 MEXICO BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 106 MEXICO BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 107 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 108 MEXICO PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 109 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 171
  • TABLE 110 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 171
  • TABLE 111 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 172
  • TABLE 112 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 172
  • TABLE 113 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 178
  • TABLE 114 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 115 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 116 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 117 EUROPE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 118 EUROPE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 119 EUROPE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 120 EUROPE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 121 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 122 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 123 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 124 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 125 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 126 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 127 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 182
  • TABLE 128 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 182
  • TABLE 129 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 182
  • TABLE 130 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 182
  • TABLE 131 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 132 GERMANY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 133 GERMANY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 134 GERMANY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 135 GERMANY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 136 GERMANY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 137 GERMANY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 138 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 139 GERMANY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 140 GERMANY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 141 GERMANY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 142 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 143 GERMANY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 144 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 186
  • TABLE 145 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 186
  • TABLE 146 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 187
  • TABLE 147 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 187
  • TABLE 148 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 149 FRANCE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 150 FRANCE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 151 FRANCE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 152 FRANCE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 153 FRANCE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 154 FRANCE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 155 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 156 FRANCE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 157 FRANCE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 158 FRANCE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 159 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 160 FRANCE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 161 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 191
  • TABLE 162 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 191
  • TABLE 163 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 192
  • TABLE 164 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 192
  • TABLE 165 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 166 U.K. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 167 U.K. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 168 U.K. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 169 U.K. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 170 U.K. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 171 U.K. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 172 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 173 U.K. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 174 U.K. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 175 U.K. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 176 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 177 U.K. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 178 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 196
  • TABLE 179 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 196
  • TABLE 180 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 197
  • TABLE 181 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 197
  • TABLE 182 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 183 ITALY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 184 ITALY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 185 ITALY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 186 ITALY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 187 ITALY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 188 ITALY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 189 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 190 ITALY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 191 ITALY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 192 ITALY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 193 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 201

LIST OF FIGURES

  • FIGURE 1 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 52
  • FIGURE 2 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 55
  • FIGURE 3 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 56
  • FIGURE 4 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 57
  • FIGURE 5 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 57
  • FIGURE 6 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 59
  • FIGURE 7 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 60
  • FIGURE 8 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 61
  • FIGURE 9 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 62
  • FIGURE 10 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 66
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 67
  • FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030 67
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 68
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL THROAT CANCER DIAGNOSTICS MARKET MANUFACTURERS IN THE FORECAST PERIOD 69
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET 78
  • FIGURE 16 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 85
  • FIGURE 17 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 86
  • FIGURE 18 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 86
  • FIGURE 19 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 87
  • FIGURE 20 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 95
  • FIGURE 21 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 96
  • FIGURE 22 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 96
  • FIGURE 23 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 97
  • FIGURE 24 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 105
  • FIGURE 25 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 106
  • FIGURE 26 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 106
  • FIGURE 27 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 107
  • FIGURE 28 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 112
  • FIGURE 29 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 113
  • FIGURE 30 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 113
  • FIGURE 31 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 114
  • FIGURE 32 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 120
  • FIGURE 33 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 121
  • FIGURE 34 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 121
  • FIGURE 35 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 122
  • FIGURE 36 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022 127
  • FIGURE 37 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 128
  • FIGURE 38 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 128
  • FIGURE 39 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 129
  • FIGURE 40 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 136
  • FIGURE 41 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 137
  • FIGURE 42 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 137
  • FIGURE 43 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 138
  • FIGURE 44 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 143
  • FIGURE 45 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY REGION (2022) 145
  • FIGURE 46 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY REGION (2023 & 2030) 145
  • FIGURE 47 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY REGION (2022 & 2030) 146
  • FIGURE 48 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: BY GRADE (2023-2030) 146
  • FIGURE 49 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 149
  • FIGURE 50 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 151
  • FIGURE 51 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 151
  • FIGURE 52 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 152
  • FIGURE 53 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 152
  • FIGURE 54 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 174
  • FIGURE 55 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 176
  • FIGURE 56 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 176
  • FIGURE 57 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 177
  • FIGURE 58 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 177
  • FIGURE 59 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 235
  • FIGURE 60 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 237
  • FIGURE 61 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 237
  • FIGURE 62 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 238
  • FIGURE 63 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 238
  • FIGURE 64 SOUTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 301
  • FIGURE 65 SOUTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 303
  • FIGURE 66 SOUTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 303
  • FIGURE 67 SOUTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 304
  • FIGURE 68 SOUTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 304
  • FIGURE 69 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 322
  • FIGURE 70 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 324
  • FIGURE 71 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 324
  • FIGURE 72 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 325
  • FIGURE 73 MIDDLE EAST AND AFRICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 325
  • FIGURE 74 GLOBAL THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 358
  • FIGURE 75 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 359
  • FIGURE 76 EUROPE THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 360
  • FIGURE 77 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 361
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!